Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Non-destructive analysis of tulobuterol crystal reservoir-type transdermal tapes using near infrared spectroscopy and imaging.

Sakamoto T, Fujimaki Y, Takada Y, Aida K, Terahara T, Kawanishi T, Hiyama Y.

J Pharm Biomed Anal. 2013 Feb 23;74:14-21. doi: 10.1016/j.jpba.2012.10.003. Epub 2012 Oct 16.

PMID:
23245228
2.

Chemical mapping of tulobuterol in transdermal tapes using microscopic laser Raman spectroscopy.

Sakamoto T, Matsubara T, Sasakura D, Takada Y, Fujimaki Y, Aida K, Miura T, Terahara T, Higo N, Kawanishi T, Hiyama Y.

Pharmazie. 2009 Mar;64(3):166-71.

PMID:
19348338
3.

Detection of tulobuterol crystal in transdermal patches using terahertz pulsed spectroscopy and imaging.

Sakamoto T, Portieri A, Taday PF, Takada Y, Sasakura D, Aida K, Matsubara T, Miura T, Terahara T, Arnone DD, Kawanishi T, Hiyama Y.

Pharmazie. 2009 Jun;64(6):361-5.

PMID:
19618670
4.

[Recent progress in NIR spectroscopy technology and its application to the field of forestry].

Gong YM, Zhang W.

Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Jul;28(7):1544-8. Chinese.

PMID:
18844157
5.
6.

Transdermal tulobuterol patch, a long-actingβ(2)-agonist.

Tamura G, Ichinose M, Fukuchi Y, Miyamoto T.

Allergol Int. 2012 Jun;61(2):219-29. doi: 10.2332/allergolint.11-RA-0358. Epub 2012 Jan 25. Review.

7.

The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration.

Kim JH, Kim TH, Park HJ, Choi YJ, Kang JH, Song KH, Koo TS, Seo KW.

Vet J. 2016 Feb;208:90-2. doi: 10.1016/j.tvjl.2015.10.012. Epub 2015 Oct 13.

PMID:
26639828
8.

[Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma].

Kato H, Nagata O, Yamazaki M, Suzuki T, Nakano Y.

Yakugaku Zasshi. 2002 Jan;122(1):57-69. Review. Japanese.

9.

Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.

Ichinose M, Seyama K, Nishimura M, Fukuchi Y, Nagai A, Mishima M, Kubo K; Beta-2 Agonist Research and Evaluation Committee in COPD (BAREC) Study Group.

Respir Med. 2010 Feb;104(2):267-74. doi: 10.1016/j.rmed.2009.09.012. Epub 2009 Oct 28.

10.

The effect of tulobuterol tape on histamine-induced bronchoconstriction in conscious guinea pigs: long duration of action.

Musoh K, Kawamura K, Miyake I, Shimada S, Ohashi T, Iwanaga Y, Morikawa K, Kato H.

Jpn J Pharmacol. 1999 Mar;79(3):401-2.

11.

A comparison of reflectance and transmittance near-infrared spectroscopic techniques in determining drug content in intact tablets.

Thosar SS, Forbess RA, Ebube NK, Chen Y, Rubinovitz RL, Kemper MS, Reier GE, Wheatley TA, Shukla AJ.

Pharm Dev Technol. 2001;6(1):19-29.

PMID:
11247272
12.

Quantitative determination of clenbuterol, salbutamol and tulobuterol enantiomers by capillary electrophoresis.

Vela J, Yanes EG, Stalcup AM.

Fresenius J Anal Chem. 2001 Feb;369(3-4):212-9.

PMID:
11293696
13.

Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.

Fukuchi Y, Nagai A, Seyama K, Nishimura M, Hirata K, Kubo K, Ichinose M, Aizawa H; Research Group TB.

Treat Respir Med. 2005;4(6):447-55.

PMID:
16336029
14.

Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.

Horiguchi T, Kondo R, Miyazaki J, Fukumokto K, Torigoe H.

Arzneimittelforschung. 2004;54(5):280-5.

PMID:
15212190
16.

Characterization of monolithic matrix patch system containing tulobuterol.

Rhee YS, Kwon SY, Park CW, Choi NY, Byun WJ, Chi SC, Park ES.

Arch Pharm Res. 2008 Aug;31(8):1029-34. doi: 10.1007/s12272-001-1264-8. Epub 2008 Sep 12.

PMID:
18787793
17.

[Studies on the relationship between physico-chemical properties and crystalline forms of tulobuterol hydrochloride. III. Hygroscopic properties of polymorphs of tulobuterol hydrochloride].

Saito M, Yamazaki M, Matsumura K, Kato H, Ito Y, Kawashima Y, Takenaka H.

Yakugaku Zasshi. 1983 Mar;103(3):336-41. Japanese. No abstract available.

PMID:
6620132
18.

Determination of terbutaline based on oxidation by voltammetry.

Yilmaz N, Ozkan SA, Uslu B, Sentürk Z, Biryol I.

J Pharm Biomed Anal. 1998 Jun;17(2):349-55.

PMID:
9638588
19.

Transdermal treatment with tulobuterol increases isometric contractile properties of diaphragm muscle in mice.

Shindoh C, Tsushima R, Shindoh Y, Tamura G.

Tohoku J Exp Med. 2007 Jul;212(3):309-17.

Supplemental Content

Support Center